World News

WHO Announces Global Strategy for Smallpox, Prioritizing ‘Strategic’ Vaccinations


The plan will last six months—September 2024 to February 2024—and will receive $135 million in funding.

The World Health Organization (WHO) is launching a global strategy to halt the transmission of mpox, the virus sometimes called monkeypox. The plan, announced Monday, will entail a “strategic vaccination” campaign.
The U.N. health agency, which declared a public health emergency of international concern two weeks ago, said that the plan will last six months—September 2024 to February 2024—and will receive $135 million in funding.

“Strategic vaccination” efforts will target people at the highest risk such as “close contacts of recent cases and healthcare workers, to interrupt transmission chains,” the agency said.

The WHO plan will focus on “implementing comprehensive surveillance, prevention, readiness, and response strategies; advancing research and equitable access to medical countermeasures like diagnostic tests and vaccines; minimizing animal-to-human transmission; and empowering communities to actively participate in outbreak prevention and control,” according to a news release.

Officials say that a subvariant of the Clade I mpox strain called Clade II has caused global concern because it seems to spread more easily through routine close contact.

WHO Director-General Tedros Adhanom Ghebreyesus said in Monday’s news release that the mpox outbreak, which originated in the Democratic Republic of the Congo, “can be controlled and can be stopped.”

“Doing so requires a comprehensive and coordinated plan of action between international agencies and national and local partners, civil society, researchers and manufacturers, and our Member States,” he added.

More Cases Confirmed Outside Africa

The Philippines has confirmed two more mpox virus infections of the milder Clade II variety, its health ministry said on Monday, bringing the number of active cases to three.

“We continue to see local transmission of mpox Clade II here in the Philippines, in Metro Manila in particular,” Secretary of Health Teodoro Herbosa said in a statement. He added that newly confirmed cases were a 37-year-old male in Metro Manila who had a rash on his body and was brought to a government hospital and a 32-year-old male from the capital who had skin lesions on his body.

The Philippines announced this past week it had detected a case of the mpox virus’ milder variant in a 33-year-old male who had no travel history outside the Philippines.

The Philippines has had 12 laboratory-confirmed cases since July 2022. The World Health Organization earlier this month declared mpox a global public health emergency, its highest form of alert, for the second time in two years, because of an outbreak in the Democratic Republic of Congo that had spread to neighboring countries.

Since January 2023, the Democratic Republic of the Congo (DRC) has reported more than 27,000 suspect mpox cases and more than 1,300 deaths.

The disease leads to flu-like symptoms and pus-filled lesions. It is usually mild but can kill. Children, pregnant women, and people with weakened immune systems, such as those with HIV, are all at higher risk of complications.

Other countries outside the African continent that have confirmed mpox cases in recent days include Sweden and Thailand.

“We have now also during the afternoon had confirmation that we have one case in Sweden of the more grave type of mpox, the one called Clade I,” Swedish Minister for Social Affairs and Public Health Jakob Forssmed told a news press conference at the time.

No Lockdowns

Earlier in August, a WHO official stressed that mpox would not cause lockdowns, closures, or restrict other activity.

“Are we going to go in lockdown in the WHO European region, it’s another COVID-19? The answer is clearly: ‘no,’” said Hans Kluge, WHO regional director for Europe, days after the WHO declaration was issued.

“Two years ago, we controlled mpox in Europe thanks to the direct engagement with the most affected communities of men who have sex with men,” he said.

In an update around the same time, the U.S. Centers for Disease Control and Prevention said that mpox currently poses a low risk to the United States and that no cases of Clade I mpox have been found in the country.

Reuters contributed to this report.



Source link

TruthUSA

I'm TruthUSA, the author behind TruthUSA News Hub located at https://truthusa.us/. With our One Story at a Time," my aim is to provide you with unbiased and comprehensive news coverage. I dive deep into the latest happenings in the US and global events, and bring you objective stories sourced from reputable sources. My goal is to keep you informed and enlightened, ensuring you have access to the truth. Stay tuned to TruthUSA News Hub to discover the reality behind the headlines and gain a well-rounded perspective on the world.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.